Penn State Cancer Institute is now the first and only oncology center in central Pennsylvania to offer patients CAR T-cell therapy, a cutting-edge treatment that has been successful treating a common type of lymphoma.
Click to view article: Penn State Cancer Institute now offering CAR T-cell therapy
On Tuesday, July 3, Penn State Health Milton S. Hershey Medical Center and the Hershey Symphony Orchestra will present “An American Salute,” the annual Independence Day celebration on the front lawn of the Medical Center.
Click to view article: Penn State Health to celebrate Independence Day with free concert on July 3
A biomimetic nanosystem can deliver therapeutic proteins to selectively target cancerous tumors, according to a team of Penn State researchers.
Click to view article: Camouflaged nanoparticles used to deliver killer protein to cancer
Natasha Renee Burse, a graduate research assistant and doctor of public health (DrPH) student at Penn State College of Medicine, is working to improve outcomes for minority women diagnosed with cancer.
Click to view article: Burse promotes benefits of exercise to minority women diagnosed with cancer
This past weekend, Penn State Health launched a new, integrated electronic health record and patient billing system—called CareConnect.
Click to view article: Penn State Health launches new integrated electronic health record and patient billing system
Penn State Health and Andrews Patel Hematology/Oncology announced today they have reached agreement to join together to provide unmatched, patient-focused oncology and hematology services to central Pennsylvania and the surrounding region.
Click to view article: Penn State Health and Andrews Patel Hematology/Oncology reach agreement
Penn State Cancer Institute are requesting applications for Development of Cancer Related Program Project Grants.
Click to view article: Request for applications open for development of cancer-related grants
The Penn State Cancer Institute has funds available through the Developmental Funds Award (DFA) to help assist investigators with the resubmission of grant applications that were recently submitted and unfunded.
Click to view article: Developmental Funds Award request for applications due June 27
Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers.
Click to view article: Genetic fixer-uppers may help predict bladder cancer prognosis
A team of medical researchers have taken a step in investigating whether a type of RNA found to be linked to cancers - called microRNAs - could one day be used as a more accurate screening test for prostate cancer.
Click to view article: MicroRNAs show signs of promise for prostate cancer screening tests
